Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the Investors Analysts on Wednesday, February 3, 2021 to discuss its Q3 FY 21 financial results.